Correlation Between Pfizer and 009158BC9
Specify exactly 2 symbols:
By analyzing existing cross correlation between Pfizer Inc and AIR PRODUCTS AND, you can compare the effects of market volatilities on Pfizer and 009158BC9 and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of 009158BC9. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and 009158BC9.
Diversification Opportunities for Pfizer and 009158BC9
Poor diversification
The 3 months correlation between Pfizer and 009158BC9 is 0.62. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and AIR PRODUCTS AND in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AIR PRODUCTS AND and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with 009158BC9. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AIR PRODUCTS AND has no effect on the direction of Pfizer i.e., Pfizer and 009158BC9 go up and down completely randomly.
Pair Corralation between Pfizer and 009158BC9
Considering the 90-day investment horizon Pfizer Inc is expected to under-perform the 009158BC9. In addition to that, Pfizer is 3.27 times more volatile than AIR PRODUCTS AND. It trades about -0.03 of its total potential returns per unit of risk. AIR PRODUCTS AND is currently generating about 0.04 per unit of volatility. If you would invest 8,158 in AIR PRODUCTS AND on September 4, 2024 and sell it today you would earn a total of 473.00 from holding AIR PRODUCTS AND or generate 5.8% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 99.31% |
| Values | Daily Returns |
Pfizer Inc vs. AIR PRODUCTS AND
Performance |
| Timeline |
| Pfizer Inc |
| AIR PRODUCTS AND |
Pfizer and 009158BC9 Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Pfizer and 009158BC9
The main advantage of trading using opposite Pfizer and 009158BC9 positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, 009158BC9 can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 009158BC9 will offset losses from the drop in 009158BC9's long position.| Pfizer vs. Crinetics Pharmaceuticals | Pfizer vs. Enanta Pharmaceuticals | Pfizer vs. Amicus Therapeutics | Pfizer vs. Connect Biopharma Holdings |
| 009158BC9 vs. The Travelers Companies | 009158BC9 vs. GE Aerospace | 009158BC9 vs. Walmart | 009158BC9 vs. Pfizer Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Other Complementary Tools
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |